{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:24:21Z","timestamp":1786721061647,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.anaerobe.2013.10.001","type":"journal-article","created":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:19:30Z","timestamp":1381882770000},"page":"79-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients"],"prefix":"10.1016","volume":"24","author":[{"given":"Eavan G.","family":"Muldoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya","family":"Logvinenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira I.","family":"Doron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Snydman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2013.10.001_bib1","unstructured":"Aldeyab MA, Kearney MP, Scott MG, et\u00a0al. An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother Aug 16."},{"key":"10.1016\/j.anaerobe.2013.10.001_bib2","doi-asserted-by":"crossref","unstructured":"Talpaert MJ, Gopal Rao G, Cooper BS, Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother Sep;66(9):2168\u201374.","DOI":"10.1093\/jac\/dkr253"},{"key":"10.1016\/j.anaerobe.2013.10.001_bib3","doi-asserted-by":"crossref","unstructured":"Freifeld AG, Bow EJ, Sepkowitz KA, et\u00a0al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis Feb 15;52(4):427\u201331.","DOI":"10.1093\/cid\/ciq147"},{"key":"10.1016\/j.anaerobe.2013.10.001_bib4","series-title":"Evaluation of a loop-mediated isothermal amplification (LAMP) assay for Clostriduium difficile as a stand-alone test for diagnosis of C difficile infection","author":"Barkin JA","year":"2011"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.anaerobe.2013.10.001_bib5","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","author":"Owens","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"Suppl.\u00a04","key":"10.1016\/j.anaerobe.2013.10.001_bib6","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1093\/clinids\/16.Supplement_4.S361","article-title":"Antibacterial activity of meropenem and selected comparative agents against anaerobic bacteria at seven North American centers","volume":"16","author":"Sheikh","year":"1993","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.anaerobe.2013.10.001_bib7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1086\/523582","article-title":"Clostridium difficile\u2013associated disease in a setting of endemicity: identification of novel risk factors","volume":"45","author":"Dubberke","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.anaerobe.2013.10.001_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/502539","article-title":"A\u00a0large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use","volume":"26","author":"Muto","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"5","key":"10.1016\/j.anaerobe.2013.10.001_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1469-0691.2009.02713.x","article-title":"Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors","volume":"15","author":"Debast","year":"2009","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.anaerobe.2013.10.001_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/505393","article-title":"A\u00a0randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies","volume":"43","author":"Bow","year":"2006","journal-title":"Clin Infect Dis"}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996413001686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996413001686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T21:37:40Z","timestamp":1564522660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996413001686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":10,"alternative-id":["S1075996413001686"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2013.10.001","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2013.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}